Evaluation of serum arginase activity in benign prostatic hypertrophy and prostatic cancer

Activities of arginase, prostatic acid phosphatase (PAP) and prostate specific antigen (PSA) were determined in sera of healthy male controls, benign prostatic hypertrophy (BPH) and prostatic cancer patients. Serum arginase activity in the cancer group (22.8+/-11.6 U/l) was significantly lower than...

Full description

Saved in:
Bibliographic Details
Published in:International urology and nephrology 1999, Vol.31 (1), p.95-99
Main Authors: Elgün, S, Keskineğe, A, Yilmaz, E, Baltaci, S, Bedük, Y
Format: Article
Language:English
Subjects:
Acid Phosphatase - blood
Aged
Arginase - blood
Clinical Enzyme Tests
Humans
Male
Middle Aged
Prostate-Specific Antigen - blood
Prostatic Hyperplasia - diagnosis
Prostatic Neoplasms - diagnosis
Reference Values
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Activities of arginase, prostatic acid phosphatase (PAP) and prostate specific antigen (PSA) were determined in sera of healthy male controls, benign prostatic hypertrophy (BPH) and prostatic cancer patients. Serum arginase activity in the cancer group (22.8+/-11.6 U/l) was significantly lower than in both the control (33.64+/-16.19 U/l) and the BPH group (58.8+/-11.6 U/l) (p
ISSN:0301-1623
1573-2584
DOI:10.1023/A:1007132109061